Asymmetric Synthesis of Activated R-Amino Esters
J . Org. Chem., Vol. 62, No. 22, 1997 7709
amine, and 45 mg (0.11 mmol) of activated ester 3c was
obtained 28 mg (83%) of dipeptide 7a after flash chromatog-
raphy (2:1 hexane/EtOAc) as a pale yellow oil. 1H NMR δ 0.89
(d, J ) 7.2 Hz, 3H), 1.33 (s, 3H), 1.43 (d, J ) 7.2 Hz, 3H), 1.52
(s, 3H), 3.43 (q, J ) 7.2 Hz, 1H), 3.72 (s, 3H), 3.94 (m, 1H),
4.30 (m, 3H), 7.37 (m, 5H). 13C NMR δ 14.2, 17.8, 21.0, 27.6,
47.5, 52.2, 54.9, 59.9, 72.4, 97.1, 127.6, 127.9, 128.8, 143.0,
173.2, 173.4. IR (film) 3377, 1744, 1671 cm-1. Anal. Calcd
for C18H26N2O4: C, 64.65; H, 7.84; N, 8.38. Found: 64.53; H,
7.73; N, 8.27.
P r ep a r a tion of P EG-Su p p or ted Tr ip ep tid e 9. To the
PEG-supported H-Leu-Gly-O-PEG7 (508 mg, 0.175 mmol)
dissolved in 2.5 mL of dry CH2Cl2 was added the pentafluo-
rophenyl (R)-alanine ester 3d (218 mg, 0.525 mmol), and the
solution was stirred at rt for 8 h. The resulting PEG-supported
tripeptide 9 (485 mg) as a white powder was purified by
precipitation with Et2O, filtration, redissolution in MeOH/CH2-
Cl2 1.5:1, and reprecipitation 3× at 0 °C to give 425 mg. 1H
NMR δ 0.75 (d, J ) 5.4 Hz, 3H), 0.84 (d, J ) 5.26 Hz, 3H),
1.23 (s, 3H), 1.36 (6H), 1.47 (m, 3H), 4.03-3.30 (m), 4.35 (m,
2H), 5.78 (1H), 7.34-7.15 (m, 5H), 7.71 (1H). 13C NMR δ 175.0,
171.8, 169.5, 143.0, 129.4, 128.3, 97.5, 73.0, 70.8, 68.5, 65.0,
64.5, 60.0, 55.0, 52.4, 41.2, 40.2, 28.2, 25.2, 23.8, 21.8, 21.2,
Dip ep tid e 7b. From 45 mg (0.21 mmol) of (S)-valine tert-
butyl ester hydrochloride, 0.11 g (0.26 mmol) activated ester
3d , N,N-dimethylaminopyridine (30 mg, 0.26 mmol), and
HOBT (6 mg, 0.04 mmol) in 2 mL of DMF was obtained 78
mg (90%) of dipeptide 7b as a pale yellow oil after flash
chromatography (5:1:1 hexane/CH2Cl2/EtOAc). 1H NMR δ 0.85
(d, J ) 6.9 Hz, 3H), 0.90 (d, J ) 6.9 Hz, 3H), 1.29 (d, J ) 7.2
Hz, 3H), 1.32 (s, 3H), 1.48 (s, 9H), 1.52 (s, 3H), 2.09 (m, 1H),
3.40 (q, J ) 7.2 Hz, 1H), 3.80 (t, J ) 7.9 Hz, 1H), 4.10 (dd, J
) 7.9, 4.2 Hz, 1H), 4.18 (t, J ) 7.5 Hz, 1H), 4.31 (t, J ) 7.7
Hz, 1H), 7.42-7.14 (m, 5H), 7.73 (d, J ) 7.7 Hz, 1H). 13C NMR
δ 174.2, 170.8, 140.0, 128.8, 128.1, 97.0, 82.0, 72.9, 61.6, 57.8,
55.4, 32.1, 28.6, 28.5, 21.8, 18.9, 18.5, 13.9. IR (film) ν 1720,
14.9. IR (film) ν 1753, 1726, 1665 cm-1
.
Clea va ge of P EG-Su p p or ted Tr ip ep tid e 9 To Give
Tr ip ep tid e 10. The PEG-supported tripeptide 9 (425 mg)
dissolved in a mixture of MeOH (1.5 mL) and DMF (1.5 mL)
was added to a flask containing 20 mg of KCN catalyst for
the cleavage. The solution was stirred at 50 °C for 36 h. The
solvent was removed under reduced pressure, and most of the
polymer was isolated by precipitation with Et2O for 4× at 0
°C (the solvent for the mixture was 1:2 of MeOH/CH2Cl2, at
40 °C), followed by filtration, and the filtrate was collected.
Traces of PEG were removed from the cleaved tripeptide by
flash chromatography on silica gel (MeOH), and the pure
tripeptide 10 (51 mg, 81% overall from 9) as a pale yellow oil
was obtained by further flash chromatography on silica gel
(10:9:1 hexane/EtOAc/MeOH). 1H NMR δ 0.79 (d, J ) 6.2 Hz,
3H), 0.88 (d, J ) 6.3 Hz, 3H), 1.27 (s, 3H), 1.41 (s, 3H), 1.43
(d, J ) 7.3 Hz, 3H), 1.50-1.63 (m, 3H), 3.41 (q, J ) 7.2 Hz,
1H), 3.59 (dd, J ) 18.1, 5.0 Hz, 1H), 3.67 (s, 3H), 3.79 (dd, J
) 18.2, 5.0 Hz, 1H), 3.79 (dd, J ) 18.2, 5.0 Hz, 1H), 3.85 (dd,
J ) 12.5, 9.2 Hz, 1H), 4.02 (m, 1H), 4.25 (m, 2H), 5.75 (t, J )
5.3 Hz, 1H), 7.13-7.35 (m, 6H). 13C NMR δ 174.7, 171.4, 169.8,
142.3, 128.8, 127.8, 127.6, 96.8, 72.3, 59.7, 54.8, 51.9, 51.8, 40.7,
39.9, 27.4, 24.6, 22.8, 21.3, 20.6, 14.0. IR (film) ν 3500-3200,
1755, 1660 cm-1. Mass (HR FAB) Calcd for C23H35O5N3: M
+ H ) 434.2655. Found: 434.2678 ( 0.0023 (∆ ) -5.6 ppm).
Oxid a t ive R em ova l of t h e Oxa zolid in e P r ot ect in g
Gr ou p . Syn th esis of Tr ip ep tid e 11. The fully protected
tripeptide 10 (0.10 g, 0.23 mmol) dissolved in 5 mL of 1:4 HCl
(1 N aqueous solution)/MeOH was stirred at rt for 2.5 h. The
solvents were removed in vacuo, and the residue was dissolved
in an aqueous sodium bicarbonate solution (5 mL of 10%
NaHCO3) followed by extraction with EtOAc (3 × 6 mL) to
give the crude product. The crude product dissolved in MeOH
was cooled to 0 °C in an ice bath, followed by addition of Pb-
(OAc)4 (0.13 g, 95%, 0.30 mmol), and the mixture was allowed
to warm to rt and stirred for 6 h. The reaction mixture was
filtered through Celite, and the Celite was washed with a 1:1
mixture solvent of MeOH/CH2Cl2, followed by removal of the
solvent under reduced pressure. The resulting intermediate
was again dissolved in a 1:4 of HCl (1 N aqueous solution)/
MeOH, and the solution was stirred at room temperature for
5 h, followed by removal of the solvent in vacuo. The residue
was dissolved in an aqueous sodium bicarbonate solution (5
mL of 10% NaHCO3), followed by extraction with EtOAc (3 ×
6 mL) to give the crude tripeptide product, which was purified
by flash chromatography on silica gel (10% MeOH/CH2Cl2) to
give 11 (48 mg, 76%) as a pale yellow oil. 1H NMR δ 0.90 (d,
J ) 5.3 Hz, 3H), 0.94 (d, J ) 5.2 Hz, 3H), 1.37 (d, J ) 6.0 Hz,
3H), 1.65 (m, 3H), 3.18 (bs, 2H), 3.69 (s, 3H), 3.72 (m, 1H),
3.98 (m, 2H), 4.49 (q, J ) 5.9 Hz, 1H), 7.51 (bs, 1H), 8.01 (bs,
1H). 13C NMR δ 175.0, 172.7, 170.4, 52.2, 51.5, 50.2, 41.0, 40.3,
1685 cm-1
. Anal. Calcd for C23H36O4N2: C, 68.29; H, 8.97.
Found: C, 68.21; H, 8.76.
Dip ep tid e 7c. From 15 mg (0.11 mmol) of (S) alanine
methyl ester hydrochloride, 61 mg (0.12 mmol) activated ester
4b, 15 µL (0.11 mmol) triethylamine, and 3 mg (0.02 mmol) of
HOBT in 2 mL of DMF was obtained 29 mg (64%) of dipeptide
7c as a clear oil after flash chromatography (2:1 hexane/
EtOAc). 1H NMR δ 0.85 (d, J ) 7.2 Hz, 3H), 1.22 (s, 3H), 1.50
(s, 3H), 1.92 (m, 1H), 2.38 (m, 1H), 2.76 (m, 1H), 2.93 (m, 1H),
3.32 (dd, J ) 4.8, 8.1 Hz, 1H), 3.72 (s, 3H), 3.93 (m, 1H), 4.26
(m, 3H), 7.28 (m, 10H). 13C NMR δ 17.7, 21.6, 27.9, 32.3, 34.8,
47.4, 52.2, 58.7, 60.2, 72.2, 96.9, 126.0, 127.6, 127.7, 128.4,
128.5, 128.9, 141.6, 143.6, 173.2, 173.3. IR (film) ν 1744, 1671
cm-1. Anal. Calcd for C25H32N2O4: C, 70.73; H, 7.60; N, 6.60.
Found: C, 70.28; H, 6.91; N, 6.54.
Dip ep tid e 7d . From 8 mg (0.06 mmol) of (S) alanine
methyl ester hydrochloride, 34 mg (0.06 mmol) of activated
ester 4d , 8 µL (0.06 mmol) triethylamine, and 2 mg (0.01
mmol) HOBT in 2 mL of DMF was obtained 15 mg (56%) of
dipeptide 7d as a clear oil after radial layer chromatography
(6:1 hexane/EtOAc). 1H NMR δ 0.87 (d, J ) 7.2 Hz, 3H), 1.38
(s, 3H), 1.53 (s, 3H), 1.65 (s, 1H), 2.12 (m, 2H), 2.58 (m, 1H),
2.71 (m, 1H), 3.32 (dd, J ) 4.5, 9.0 Hz, 1H), 3.68 (s, 3H), 3.71
(s, 3H), 3.94 (m, 1H), 4.20 (m, 1H), 4.31 (m, 2H), 7.31 (m, 5H).
13C NMR δ 17.7, 21.6, 25.4, 27.9, 32.4, 47.5, 51.6, 52.2, 58.2,
60.2, 72.2, 97.0, 127.7, 127.7, 128.9, 143.3, 172.9, 173.2, 173.6.
IR (film) ν 1740, 1670 cm-1. HRMS Calcd for C21H30N2O6: [M
+ H] ) 407.2177. Found: [M + H] ) 407.2182.
Dip ep tid e 7e. From 7 mg (0.05 mmol) of (S) alanine
methyl ester hydrochloride, 19 mg (0.04 mmol) of activated
ester 4e, 7 µL of triethylamine, and 1.1 mg of HOBT was
obtained 10 mg (63%) of dipeptide 7e as a clear oil after radial
layer chromatography (3:1 hexane/EtOAc). 1H NMR δ 0.87
(m, 6H), 1.27 (bs, 14H), 1.34 (s, 3H), 1.52 (s, 3H), 1.66 (m, 2H),
1.89 (m, 1H), 3.25 (t, J ) 6.8 Hz, 1H), 3.71 (s, 3H), 3.93 (dd, J
) 3.2, 8.0 Hz, 1H), 4.27 (m, 3H), 7.32 (m, 5H). 13C NMR δ
14.1, 17.8, 21.9, 22.6, 28.0, 28.6, 29.3, 29.4, 29.6, 29.8, 30.4,
31.8, 47.4, 52.1, 60.3, 72.2, 96.8, 127.5, 127.6, 128.9, 144.0,
173.2, 173.8. IR (film) ν 1745, 1673 cm-1
. Anal. Calcd for
C26H42N2O4: C, 69.92; H, 9.48; N, 6.27. Found: C, 70.16; H,
9.21; N, 6.35.
24.8, 22.8, 21.8, 20.7. IR (film) ν 1740, 1768 cm-1
.
Dip ep tid e 8. From 15 mg (0.09 mmol) of (S) proline methyl
ester hydrochloride, 42 mg (0.10 mol) of activated ester 3b,
15 µL of triethylamine, and 3 mg of HOBT was obtained 27
mg (74%) of dipeptide 8 as a yellow oil after flash chromatog-
raphy (1:1 hexane/EtOAc). 1H NMR δ 1.31 (d, J ) 6.0 Hz,
3H), 1.47 (s, 6H), 1.77-1.97 (m, 4H), 3.56 (m, 2H), 3.60 (s, 3H),
3.73 (dd, J ) 8.4, 5.2 Hz, 1H), 3.84 (m, 2H), 4.24 (t, J ) 8.2
Red u ctive Rem ova l of th e Oxa zolid in e Ch ir a l Au xil-
ia r y fr om th e F u lly P r otected Tr ip ep tid e 10 a n d P r ep a -
r a tion of 11. The fully protected tripeptide 10 (0.10 g, 0.23
mmol) dissolved in 5 mL of 1:4 HCl (1 N aqueous solution)/
MeOH was stirred at rt for 2.5 h, the solvents were removed
in vacuo, and the residue was dissolved in an aqueous sodium
bicarbonate solution (5 mL of 10% NaHCO3) followed by
extraction with EtOAc (3 × 6 mL) to give the crude product.
The crude product dissolved in 5 mL of MeOH was transferred
to a pressure tube containing the Pearlman’s catalyst (98 mg,
20% Pd(OH)2/C, 0.069 mmol). A pressure head was attached,
Hz, 1H), 4.39 (dd, J ) 7.9, 5.2 Hz, 1H), 7.17-7.29 (m, 5H). 13
C
NMR δ 173.0, 170.2, 144.0, 127.8, 126.8, 96.8, 71.2, 60.1, 58.8,
53.6, 51.9, 46.2, 28.7, 28.1, 24.9, 24.5, 13.3. IR (film) ν 1749,
1644 cm-1
.
Anal. Calcd for C20H28O4N2: C, 66.65; H, 7.83.
Found: C, 66.78; H, 7.59.